Search Results

There are 1021 results for: content related to: Comparison of stool microbiota compositions, stool alpha1-antitrypsin and calprotectin concentrations, and diarrhoeal morbidity of I ndonesian infants fed breast milk or probiotic/prebiotic-supplemented formula

  1. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 12, Issue 6, June 2006, Pages: 524–534, Michael R. Konikoff and Lee A. Denson

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200606000-00013

  2. High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6

    Clinical & Experimental Allergy

    Volume 45, Issue 5, May 2015, Pages: 928–939, L. Orivuori, K. Mustonen, M. C. de Goffau, S. Hakala, M. Paasela, C. Roduit, J.-C. Dalphin, J. Genuneit, R. Lauener, J. Riedler, J. Weber, E. von Mutius, J. Pekkanen, H. J. M. Harmsen, O. Vaarala and the PASTURE Study Group

    Version of Record online : 16 APR 2015, DOI: 10.1111/cea.12522

  3. The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 5, September 2016, Pages: 495–504, Y. Zhulina, Y. Cao, K. Amcoff, M. Carlson, C. Tysk and J. Halfvarson

    Version of Record online : 12 JUL 2016, DOI: 10.1111/apt.13731

  4. You have free access to this content
    Emerging role of calprotectin in gastroenterology

    Journal of Gastroenterology and Hepatology

    Volume 18, Issue 7, July 2003, Pages: 756–762, ANDREW POULLIS, RUSSELL FOSTER, MICHAEL A MENDALL and MAGNE K FAGERHOL

    Version of Record online : 10 JUN 2003, DOI: 10.1046/j.1440-1746.2003.03014.x

  5. Salivary calprotectin levels are raised in patients with oral candidiasis or Sjögren’s syndrome but decreased by HIV infection

    Oral Microbiology and Immunology

    Volume 16, Issue 2, April 2001, Pages: 119–123, S. P. Sweet, A. N. Denbury and S. J. Challacombe

    Version of Record online : 21 DEC 2001, DOI: 10.1034/j.1399-302x.2001.016002119.x

  6. Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors

    Arthritis Care & Research

    Volume 68, Issue 7, July 2016, Pages: 899–906, José Inciarte-Mundo, Maria Victoria Hernández, Virginia Ruiz-Esquide, Sonia Raquel Cabrera-Villalba, Julio Ramirez, Andrea Cuervo, Mariona Pascal, Jordi Yagüe, Juan D. Cañete and Raimon Sanmarti

    Version of Record online : 23 JUN 2016, DOI: 10.1002/acr.22795

  7. Induction of calprotectin release by Porphyromonasgingivalis lipopolysaccharide in human neutrophils

    Oral Microbiology and Immunology

    Volume 19, Issue 3, June 2004, Pages: 182–187, J. Kido, R. Kido, Suryono, M. Kataoka, M. K. Fagerhol and T. Nagata

    Version of Record online : 26 APR 2004, DOI: 10.1111/j.0902-0055.2004.00139.x

  8. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

    Inflammatory Bowel Diseases

    Volume 15, Issue 8, August 2009, Pages: 1190–1198, Javier P. Gisbert, Fernando Bermejo, Jose-Lázaro Pérez-Calle, Carlos Taxonera, Isabel Vera, Adrian G. McNicholl, Alicia Algaba, Pilar López, Natalia López-Palacios, Marta Calvo, Yago González-Lama, Jose-Antonio Carneros, Marta Velasco and José Maté

    Version of Record online : 16 MAR 2009, DOI: 10.1002/ibd.20933

  9. You have free access to this content
    Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis

    Journal of Internal Medicine

    Volume 270, Issue 1, July 2011, Pages: 50–57, K. Andréasson, A. Scheja, T. Saxne, B. Ohlsson and R. Hesselstrand

    Version of Record online : 9 JAN 2011, DOI: 10.1111/j.1365-2796.2010.02340.x

  10. Calprotectin release from human neutrophils is induced by Porphyromonas gingivalis lipopolysaccharide via the CD-14–Toll-like receptor–nuclear factor κB pathway

    Journal of Periodontal Research

    Volume 38, Issue 6, December 2003, Pages: 557–563, Jun-ichi Kido, Reiko Kido, , Masatoshi Kataoka, Magne K. Fagerhol and Toshihiko Nagata

    Version of Record online : 30 OCT 2003, DOI: 10.1034/j.1600-0765.2003.00691.x

  11. You have free access to this content
    Calprotectin is released from human skeletal muscle tissue during exercise

    The Journal of Physiology

    Volume 586, Issue 14, July 2008, Pages: 3551–3562, Ole Hartvig Mortensen, Kasper Andersen, Christian Fischer, Anders Rinnov Nielsen, Søren Nielsen, Thorbjörn Åkerström, Maj-brit Aastrøm, Rehannah Borup and Bente Klarlund Pedersen

    Version of Record online : 14 JUL 2008, DOI: 10.1113/jphysiol.2008.153551

  12. Proinflammatory cytokines upregulate expression of calprotectin (L1 protein, MRP-8/MRP-14) in cultured human keratinocytes

    British Journal of Dermatology

    Volume 149, Issue 3, September 2003, Pages: 484–491, G. Mørk, H. Schjerven, L. Mangschau, E. Søyland and P. Brandtzaeg

    Version of Record online : 23 SEP 2003, DOI: 10.1046/j.1365-2133.2003.05536.x

  13. Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis

    Liver International

    Volume 31, Issue 9, October 2011, Pages: 1406–1415, Felix Gundling, Fabian Schmidtler, Alexander Hapfelmeier, Benjamin Schulte, Thomas Schmidt, Christian Pehl, Wolfgang Schepp and Holger Seidl

    Version of Record online : 6 SEP 2011, DOI: 10.1111/j.1478-3231.2011.02577.x

  14. Calprotectin levels in gingival crevicular fluid predict disease activity in patients treated for generalized aggressive periodontitis

    Journal of Periodontal Research

    Volume 46, Issue 4, August 2011, Pages: 417–426, D. Kaner, J.-P. Bernimoulin, T. Dietrich, B.-M. Kleber and A. Friedmann

    Version of Record online : 13 APR 2011, DOI: 10.1111/j.1600-0765.2011.01355.x

  15. Ascitic Calprotectin is a Novel and Accurate Marker for Spontaneous Bacterial Peritonitis

    Journal of Clinical Laboratory Analysis

    Volume 30, Issue 6, November 2016, Pages: 1139–1145, Samuel Raimundo Fernandes, Patrícia Santos, Narcisa Fatela, Cilénia Baldaia, Rui Tato Marinho, Helena Proença, Fernando Ramalho and José Velosa

    Version of Record online : 17 MAY 2016, DOI: 10.1002/jcla.21994

  16. Calprotectin in microglia from frontal cortex is up-regulated in schizophrenia: evidence for an inflammatory process?

    European Journal of Neuroscience

    Volume 24, Issue 12, December 2006, Pages: 3561–3566, Russell Foster, Apsara Kandanearatchi, Claire Beasley, Brenda Williams, Nadeem Khan, Magne K. Fagerhol and Ian P. Everall

    Version of Record online : 12 DEC 2006, DOI: 10.1111/j.1460-9568.2006.05219.x

  17. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 12, December 2012, Pages: 2218–2224, Geert D'Haens, Marc Ferrante, Severine Vermeire, Filip Baert, Maja Noman, Liesbeth Moortgat, Patricia Geens, Doreen Iwens, Isolde Aerden, Gert Van Assche, Gust Van Olmen and Paul Rutgeerts

    Version of Record online : 16 FEB 2012, DOI: 10.1002/ibd.22917

  18. You have free access to this content
    The ZrfC alkaline zinc transporter is required for Aspergillus fumigatus virulence and its growth in the presence of the Zn/Mn-chelating protein calprotectin

    Cellular Microbiology

    Volume 16, Issue 4, April 2014, Pages: 548–564, Jorge Amich, Rocío Vicentefranqueira, Emilia Mellado, Ana Ruiz-Carmuega, Fernando Leal and José Antonio Calera

    Version of Record online : 4 DEC 2013, DOI: 10.1111/cmi.12238

  19. Calprotectin and neutrophil gelatinase–associated lipocalin in the differentiation of pre-renal and intrinsic acute kidney injury

    Acta Physiologica

    Volume 207, Issue 4, April 2013, Pages: 700–708, F. S. Seibert, N. Pagonas, R. Arndt, F. Heller, D. Dragun, P. Persson, K. Schmidt-Ott, W. Zidek and T. H. Westhoff

    Version of Record online : 14 FEB 2013, DOI: 10.1111/apha.12064

  20. Plasma Calprotectin Predicts Mortality in Patients with ST Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

    Journal of Interventional Cardiology

    Volume 23, Issue 2, April 2010, Pages: 123–129, LOUISE J. N. JENSEN, SUNE PEDERSEN, METTE BJERRE, RASMUS MOGELVANG, JAN SKOV JENSEN and ALLAN FLYVBJERG

    Version of Record online : 12 MAR 2010, DOI: 10.1111/j.1540-8183.2010.00532.x